免疫系统
免疫疗法
结直肠癌
肿瘤微环境
癌症
免疫原性
免疫抑制
癌症免疫疗法
免疫检查点
医学
免疫学
癌症研究
内科学
作者
Yang Xiong,Ying Wang,Karthik Tiruthani
标识
DOI:10.1016/j.nano.2019.102034
摘要
Colorectal cancer (CRC) is predicted to be the second leading cause of cancer-related death in United States in 2019. Immunotherapies such as checkpoint inhibitors have proven efficacy in patients with high level of microsatellite instability and refractory to routine chemotherapy. Despite this, immunotherapy-based treatment is seriously limited by cancer immunogenicity which has evolved to evade immune surveillance in many circumstances. Efforts are made by researchers using nanoparticles (NPs) to override cancer-mediated immunosuppression, induce immune response against cancer cells or even generate memory immune cells for long-term disease control. These engineered NPs offer great opportunities in delivering cancer immunotherapy due to their unique properties, such as a high drug/antigen loading capacity, adjustable particle size, and versatile surface modification. In this review, we will highlight recent researches on the initiation and development of CRC, the immune microenvironment of CRC, and recent trends in engineering novel NPs-based immunotherapies in the treatment of CRC.
科研通智能强力驱动
Strongly Powered by AbleSci AI